Page 2 - Best Meningioma doctors: TOP 68 doctors

Dr. Dvora Blumental leads the Neuro-oncology Service at Sourasky Medical Center, specializing in meningioma care with 30 years of experience of focused experience.

• Trained at Memorial Sloan-Kettering Cancer Center – one of the world's top cancer hospitals
• Previously directed the Neuro-oncology Service at Huntsman Cancer Institute
• Senior neuro-oncologist since 1998 – vast experience with complex brain tumors
• Fellowship-trained in neuro-oncology at Memorial Sloan-Kettering

Dr. Yildiz specializes in neuroendocrine and rare tumors, with extensive research and clinical experience at Medipol Mega University Hospital.

• Published 17+ papers on neuroendocrine and rare tumors
• Expertise in diagnosing and managing complex tumor cases
• Active member of multiple international medical research studies

Prof. Köstler is a leading expert in targeted cancer therapies with over two decades of experience, specializing in breast and gynecologic malignancies.

• Completed training at the Medical University of Vienna
• Focuses on individualized systemic cancer therapy and immunotherapy
• Deputy Head of the Clinical Division of Oncology
• Published research in biomarker development and tumor biology

Associate Professor Tahsin Ozatli specializes in oncology with extensive experience across multiple cancer types, currently practicing at Istinye Liv University Hospital.

• Specializes in breast, lung, and gastrointestinal cancers
• Internal Medicine Specialist at Malatya State Hospital
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Studied medicine at Selcuk University

Professor Keil specializes in advanced imaging techniques for complex interventions, currently leading the Diagnostic and Interventional Radiology Clinic in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided procedures
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for all body regions

Specializes in comprehensive tumor treatment, including cutting-edge immunotherapy and molecular diagnostics at Medical Center in Solingen.

• Board-certified in hematology, oncology, and immunology
• Chief Physician at a certified interdisciplinary cancer center
• Active in molecular biology research for innovative cancer therapies
• Qualified specialist in genetics
• Member of leading oncology societies including American Association for Cancer Research

Assoc. Prof. Nail Paksoy brings specialized expertise in oncology to Medipol Bahçelievler Hospital, with a focus on targeted therapies.

• Over 15 years of experience of medical oncology fellowship training
• Active participant in international clinical trials for various cancers
• ESMO Board Certified in Medical Oncology
• Published multiple research papers on innovative cancer treatments
• Associate professor at Istanbul Medipol University

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Specialized in Medical Oncology with extensive training at Akdeniz University – Dr. Alemdar brings focused expertise to meningioma cases at Medical Park Antalya.

• Graduated from Kocaeli University Faculty of Medicine
• Completed Medical Oncology specialization in 2018
• Works at Medical Park Antalya Hospital Complex
• 20 years of experience of clinical experience

Dr. Inta Jaunalksne specializes in virotherapy, a cutting-edge immunology approach, with 49 years of experience of experience. She leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute
• Completed internship in Internal Medicine
• Head of Clinical Immunology Center

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Francesc Graus is a pioneer in neuro-oncology, leading the panel that defined diagnostic criteria for paraneoplastic neurological syndromes.

• Specializes in gliomas and primary brain lymphomas
• Founder and past president of the European Association of Neuro-Oncology
• Trained in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center
• Honored with Doctor Honoris Causa by Lyon University